Detalles de la búsqueda
1.
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
BMC Med
; 21(1): 400, 2023 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37872545
2.
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
Int J Cancer
; 147(11): 3085-3089, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32492185
3.
Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance.
Bioorg Med Chem Lett
; 29(7): 882-889, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30755336
4.
Health Disinformation Use Case Highlighting the Urgent Need for Artificial Intelligence Vigilance: Weapons of Mass Disinformation.
JAMA Intern Med
; 184(1): 92-96, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955873
5.
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis.
BMJ
; 384: e078538, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508682
6.
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation.
J Clin Epidemiol
; 167: 111263, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38219810
7.
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages.
JAMA Oncol
; 9(12): 1621-1626, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796495
8.
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration.
JAMA Oncol
; 8(9): 1310-1316, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900732
9.
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib.
Breast
; 58: 57-62, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906086
10.
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data.
NPJ Breast Cancer
; 7(1): 30, 2021 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753745
11.
Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine.
J Cancer
; 11(11): 3327-3333, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231738
12.
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine.
Clin Breast Cancer
; 20(2): e220-e228, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892489
13.
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data.
Front Oncol
; 10: 1130, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32760671
14.
A literature review of treatment-specific clinical prediction models in patients with breast cancer.
Crit Rev Oncol Hematol
; 148: 102908, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32109714
15.
Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis.
Front Pharmacol
; 12: 732622, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34421624
Resultados
1 -
15
de 15
1
Próxima >
>>